+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Immuno Oncology Assays Market by Technology Type (Flow Cytometry, Immunoassay, Mass Cytometry), Product (Consumables, Instruments), Sample Type, End User, Indication, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337689
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Immuno oncology assays are playing an increasingly pivotal role in cancer research and precision medicine, enabling organizations to better characterize immune activity within the tumor microenvironment and respond to the evolving demands of personalized treatment strategies.

Market Snapshot: Immuno Oncology Assays Market Overview

The Immuno Oncology Assays Market grew from USD 7.21 billion in 2024 to USD 8.33 billion in 2025. It is expected to continue growing at a CAGR of 15.30%, reaching USD 16.95 billion by 2030. Growth is driven by increasing clinical adoption of high-parameter flow and mass cytometry platforms, a surge of novel immune checkpoint inhibitors entering practice, and an expanded focus on robust assay technologies that directly support stratified care and therapeutic innovation.

Scope & Segmentation

This research offers a comprehensive analysis of the immuno oncology assays landscape, including regional dynamics, technology platforms, and market segmentation:

  • Technology Types: Flow cytometry, immunoassay formats (ELISA, multiplex immunoassay), mass cytometry, and next generation sequencing approaches
  • Product Categories: Consumables such as probes, antibodies, reagents, and kits; instruments including automated systems and platform-based solutions
  • Sample Types: Blood, cell lines, and diverse tissue specimens
  • End Users: Academic and research institutes, diagnostic laboratories, hospitals and clinics, pharmaceutical and biotech companies
  • Indications: Breast cancer, hematologic cancers, lung cancer, and melanoma applications
  • Applications: Biomarker discovery, companion diagnostics, cytokine analysis, immune monitoring, tumor microenvironment analysis
  • Regions Covered: Americas, Europe, Middle East & Africa, Asia-Pacific, with analysis of leading countries and sub-regional variations
  • Key Company Coverage: Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies, Reaction Biology Corporation, Bio-Rad Laboratories, Creative Biolabs, QIAGEN, Illumina, and Becton, Dickinson and Company

Key Takeaways

  • Adoption of multiplex immunoassay systems and high-parameter cytometry is transforming biomarker discovery and immune monitoring capabilities.
  • A focus on personalized oncology and companion diagnostics is redefining how assays are integrated into treatment selection and patient stratification.
  • Collaborations between diagnostics manufacturers, academic institutions, and pharmaceutical firms are creating new synergies that accelerate development and drive data quality improvements.
  • Standardization and harmonization in assay protocols are gaining attention from regulatory bodies, prompting alignment between analytical rigor and workflow efficiency.
  • Integration of bioinformatics and machine learning into assay workflows allows deeper interpretation of complex patient data sets and supports discovery of new clinical insights.
  • Regional differences in infrastructure, reimbursement, and regulatory frameworks significantly impact technology adoption rates and market expansion strategies.

Tariff Impact: Navigating U.S. Tariff Measures

Recent U.S. tariff measures are shaping procurement and operational frameworks for assay manufacturers and end users. Increased import duties on reagents, antibodies, and instrumentation sourced internationally are elevating costs and influencing companies to diversify supplier networks or localize production. These market forces are driving organizations to refine their risk management and forecast models, ensuring continued assay performance and reliability despite evolving trade conditions.

Methodology & Data Sources

This report leverages a robust research methodology, combining extensive secondary research from peer-reviewed publications and regulatory filings with primary interviews of subject matter experts. Quantitative surveys validate end-user perspectives, while triangulation and proprietary statistical models uphold analytical accuracy and consistent industry coverage.

Why This Report Matters

  • Empowers decision-makers with detailed insights on technologies, trends, and competitive developments shaping immuno oncology assays.
  • Delivers actionable guidance for optimizing technology adoption, navigating regulatory landscapes, and sustaining competitive advantage.

Conclusion

The immuno oncology assays market is rapidly evolving, shaped by technological advances, regulatory developments, and dynamic regional factors. A proactive, informed strategy is vital for organizations aiming to achieve success in this expanding domain.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of high-content imaging assays for simultaneous analysis of immune cell phenotypes and functions in tumor microenvironment
5.2. Development of liquid biopsy-based assays for noninvasive monitoring of immune checkpoint inhibitor efficacy in cancer patients
5.3. Expansion of multiplexed cytokine profiling platforms enabling detailed assessment of immunotherapy-induced biomarkers in real time
5.4. Advancements in single-cell sequencing assays to characterize T-cell receptor diversity and clonality in response to immunotherapy
5.5. Commercialization of standardized PD-L1 IHC assays with digital pathology integration for improved predictive accuracy
5.6. Emergence of neoantigen-based peptide proliferation assays to personalize cancer vaccine development and patient selection
5.7. Adoption of automation and microfluidics in immunoassays to increase throughput and reproducibility in clinical trial settings
5.8. Regulatory guidelines evolution for companion diagnostic immunoassays aligning with novel immune checkpoint targets and combinations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Immuno Oncology Assays Market, by Technology Type
8.1. Introduction
8.2. Flow Cytometry
8.2.1. Conventional Flow Cytometry
8.2.2. Spectral Flow Cytometry
8.3. Immunoassay
8.3.1. Elisa
8.3.2. Multiplex Immunoassay
8.4. Mass Cytometry
8.5. Next Generation Sequencing
8.5.1. Targeted Panel
8.5.2. Whole Exome Sequencing
8.5.3. Whole Genome Sequencing
9. Immuno Oncology Assays Market, by Product
9.1. Introduction
9.2. Consumables
9.2.1. Probes And Antibodies
9.2.2. Reagents And Kits
9.3. Instruments
9.3.1. Automated Systems
9.3.2. Platform Based Instruments
10. Immuno Oncology Assays Market, by Sample Type
10.1. Introduction
10.2. Blood
10.3. Cell Lines
10.4. Tissue
11. Immuno Oncology Assays Market, by End User
11.1. Introduction
11.2. Academic And Research Institutes
11.2.1. Research Institutes
11.2.2. Universities
11.3. Diagnostic Laboratories
11.4. Hospitals And Clinics
11.5. Pharmaceutical And Biotech
12. Immuno Oncology Assays Market, by Indication
12.1. Introduction
12.2. Breast Cancer
12.3. Hematologic Cancers
12.4. Lung Cancer
12.5. Melanoma
13. Immuno Oncology Assays Market, by Application
13.1. Introduction
13.2. Biomarker Discovery
13.3. Companion Diagnostics
13.4. Cytokine Analysis
13.5. Immune Monitoring
13.6. Tumor Microenvironment Analysis
14. Americas Immuno Oncology Assays Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Immuno Oncology Assays Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Immuno Oncology Assays Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Danaher Corporation
17.3.3. Merck KGaA
17.3.4. Agilent Technologies, Inc.
17.3.5. Reaction Biology Corporation
17.3.6. Bio-Rad Laboratories, Inc.
17.3.7. Creative Biolabs
17.3.8. QIAGEN N.V.
17.3.9. Illumina, Inc.
17.3.10. Becton, Dickinson and Company
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. IMMUNO ONCOLOGY ASSAYS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. IMMUNO ONCOLOGY ASSAYS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. IMMUNO ONCOLOGY ASSAYS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. IMMUNO ONCOLOGY ASSAYS MARKET: RESEARCHAI
FIGURE 28. IMMUNO ONCOLOGY ASSAYS MARKET: RESEARCHSTATISTICS
FIGURE 29. IMMUNO ONCOLOGY ASSAYS MARKET: RESEARCHCONTACTS
FIGURE 30. IMMUNO ONCOLOGY ASSAYS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. IMMUNO ONCOLOGY ASSAYS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SPECTRAL FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SPECTRAL FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MULTIPLEX IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MULTIPLEX IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MASS CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MASS CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TARGETED PANEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TARGETED PANEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PROBES AND ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PROBES AND ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PLATFORM BASED INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PLATFORM BASED INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CELL LINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CELL LINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HEMATOLOGIC CANCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HEMATOLOGIC CANCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MELANOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MELANOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CYTOKINE ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CYTOKINE ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TUMOR MICROENVIRONMENT ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TUMOR MICROENVIRONMENT ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 155. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 156. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 157. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 158. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 159. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 160. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 161. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 162. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 163. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 164. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 165. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 166. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 167. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 168. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 169. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 170. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 171. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 174. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 175. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 176. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 177. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 180. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 181. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 182. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 183. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 184. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 185. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 186. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 187. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 188. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 189. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 190. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 191. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 192. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 193. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 194. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 195. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 198. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 199. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 200. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 201. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 302. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 303. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 304. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 305. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 306. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 307. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 308. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 309. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 310. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 311. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 312. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 313. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 314. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 315. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 316. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 317. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 320. GERMANY IMMUNO ONCOLOGY

Samples

Loading
LOADING...

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Reaction Biology Corporation
  • Bio-Rad Laboratories, Inc.
  • Creative Biolabs
  • QIAGEN N.V.
  • Illumina, Inc.
  • Becton, Dickinson and Company

Table Information